Full Title
First-in-Human, Phase 1 Study of ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Alan Ho’s office at 646-608-3774.
Protocol
26-360
Phase
Phase I (phase 1)
Investigator
Co-Investigators
Locations
ClinicalTrials.gov ID
NCT06597721
ClinicalTrials.gov